Business
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
WALTHAM, Mass., September 15, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable,
About this update from Thermo Fisher Scientific Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1590,"height":341,"url":"https://media.zenfs.com/en/business-wire.com/2ab4eeab470a681e36a773af85b3185e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/64yctDzwNpNRcnPVOajlGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIwNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2ab4eeab470a681e36a773af85b3185e","width":960,"height":206},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/X3aibknRyNi_P9aaD8aYGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01MTQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/2ab4eeab470a681e36a773af85b3185e","width":1200,"height":257}},"lazy":false},{"type":"text","content":"Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay","length":111,"tagName":"p","attribs":{}},{"type":"text","content":"WALTHAM, Mass., September 15, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, reproducible and disease-relevant protein measurement. This panel delivers simultaneous measurement of 41 key and emerging proteins for neurodegeneration research with absolute quantification and optimized for plasma measurement from as little as 1µL of sample.","length":779,"tagName":"p"},{"type":"text","content":"The Target 48 Neurodegeneration panel is the latest addition to Olink’s growing portfolio of multiplex disease panels with absolute quantification readouts. Alongside the Olink® Target 48 Cytokine, Olink® Target 48 Immune Surveillance, and the semi-custom Olink® Flex platform, this solution helps create a powerful ecosystem for proteomics research. When combined, these panels allow researchers to seamlessly analyze a larger library of protein biomarkers that can help provide comprehensive insights into neurodegeneration and inflammation in the body.","length":555,"tagName":"p"},{"type":"text","content":"...